Brittany L Bychkovsky (B L Bychkovsky)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Early Breast Cancer

Dna Methylation

Endometrial Cancer

Top Venues

Nature communications

JCO precision oncology

NPJ breast cancer

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Stefania Morganti, Qingchun Jin, Julie Vincuilla, Ryan Buehler, Sean Ryan, Samantha Stokes, Tonia Parker, Elizabeth A Mittendorf, Tari A King, Anna Weiss, Ann H Partridge, Brittany L Bychkovsky, Curigliano Giuseppe, Nabihah Tayob, Nancy U Lin, Judy E Garber, Sara M Tolaney, Filipa C Lynce
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer. NPJ breast cancer 10 (1) (2024)
Stefania Morganti, Qingchun Jin, Julie Vincuilla, Ryan Buehler, Sean Ryan, Samantha Stokes, Tonia Parker, Elizabeth A Mittendorf, Tari A King, Anna Weiss, Ann H Partridge, Brittany L Bychkovsky, Curigliano Giuseppe, Nabihah Tayob, Nancy U Lin, Judy E Garber, Sara M Tolaney, Filipa C Lynce
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer. NPJ breast cancer 10 (1) (2024)
Stefania Morganti, Qingchun Jin, Julie Vincuilla, Ryan Buehler, Sean Ryan, Samantha Stokes, Tonia Parker, Elizabeth A Mittendorf, Tari A King, Anna Weiss, Ann H Partridge, Brittany L Bychkovsky, Curigliano Giuseppe, Nabihah Tayob, Nancy U Lin, Judy E Garber, Sara M Tolaney, Filipa C Lynce
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer. NPJ breast cancer 10 (1) (2024)
Kimia Sorouri, Filipa C Lynce, Colleen M Feltmate, Michelle R Davis, Michael G Muto, Panagiotis A Konstantinopoulos, Elizabeth H Stover, Allison W Kurian, Sarah J Hill, Ann H Partridge, Sara M Tolaney, Judy E Garber, Brittany L Bychkovsky
Endometrial Cancer Risk Among Germline BRCA1 / 2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps. JCO precision oncology 7 (2023)
Brittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, Carrie Horton, Parichehr Hemyari, Holly LaDuca, Judy E Garber, Rochelle Scheib, Huma Q Rana
Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception. Breast cancer research and treatment (2023)
Brittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, Carrie Horton, Parichehr Hemyari, Holly LaDuca, Judy E Garber, Rochelle Scheib, Huma Q Rana
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast cancer research and treatment (2023)
Kimia Sorouri, Filipa C Lynce, Colleen M Feltmate, Michelle R Davis, Michael G Muto, Panagiotis A Konstantinopoulos, Elizabeth H Stover, Allison W Kurian, Sarah J Hill, Ann H Partridge, Sara M Tolaney, Judy E Garber, Brittany L Bychkovsky
Endometrial Cancer Risk Among Germline BRCA1 / 2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps. JCO precision oncology 7 (2023)
Paolo Tarantino, Hersh Gupta, Melissa E Hughes, Janet Files, Sarah Strauss, Gregory Kirkner, Anne-Marie Feeney, Yvonne Li, Ana Christina Garrido-Castro, Romualdo Barroso-Sousa, Brittany L Bychkovsky, Simona DiLascio, Lynette M Sholl, Laura MacConaill, Neal Lindeman, Bruce E Johnson, Matthew L Meyerson, Rinath M Jeselsohn, Xintao Qiu, Rong Li, Henry W Long, Eric P Winer, Deborah Dillon, Curigliano Giuseppe, Andrew D Cherniack, Sara M Tolaney, Nancy U Lin
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nature communications 14 (1) (2023)
Paolo Tarantino, Hersh Gupta, Melissa E Hughes, Janet Files, Sarah Strauss, Gregory Kirkner, Anne-Marie Feeney, Yvonne Li, Ana Christina Garrido-Castro, Romualdo Barroso-Sousa, Brittany L Bychkovsky, Simona DiLascio, Lynette M Sholl, Laura MacConaill, Neal Lindeman, Bruce E Johnson, Matthew L Meyerson, Rinath M Jeselsohn, Xintao Qiu, Rong Li, Henry W Long, Eric P Winer, Deborah Dillon, Curigliano Giuseppe, Andrew D Cherniack, Sara M Tolaney, Nancy U Lin
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nature communications 14 (1) (2023)
Kimia Sorouri, Filipa C Lynce, Colleen M Feltmate, Michelle R Davis, Michael G Muto, Panagiotis A Konstantinopoulos, Elizabeth H Stover, Allison W Kurian, Sarah J Hill, Ann H Partridge, Sara M Tolaney, Judy E Garber, Brittany L Bychkovsky
Endometrial Cancer Risk Among Germline BRCA1 / 2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps. JCO precision oncology 7 (2023)
Paolo Tarantino, Hersh Gupta, Melissa E Hughes, Janet Files, Sarah Strauss, Gregory Kirkner, Anne-Marie Feeney, Yvonne Li, Ana Christina Garrido-Castro, Romualdo Barroso-Sousa, Brittany L Bychkovsky, Simona DiLascio, Lynette M Sholl, Laura MacConaill, Neal Lindeman, Bruce E Johnson, Matthew L Meyerson, Rinath M Jeselsohn, Xintao Qiu, Rong Li, Henry W Long, Eric P Winer, Deborah Dillon, Curigliano Giuseppe, Andrew D Cherniack, Sara M Tolaney, Nancy U Lin
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nature communications 14 (1) (2023)
Paolo Tarantino, H Gupta, M E Hughes, J Files, S Strauss, G Kirkner, A-M Feeney, Y Li, Ana Christina Garrido-Castro, R Barroso-Sousa, Brittany L Bychkovsky, S DiLascio, Lynette M Sholl, L MacConaill, N Lindeman, B E Johnson, Matthew L Meyerson, Rinath M Jeselsohn, Xintao Qiu, Rong Li, Henry W Long, E P Winer, D Dillon, Curigliano Giuseppe, A D Cherniack, Sara M Tolaney, N U Lin
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nature communications 14 (1) (2023)